Your session is about to expire
← Back to Search
Mobile Cognitive Behavioral Therapy App for Anxiety and Depression
N/A
Recruiting
Led By Jennifer Bress, Ph.D.
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to end of active learning phase [week 4 for personalized intervention and week 6 for the general intervention]
Awards & highlights
Summary
This trial aims to compare two mobile CBT programs for anxiety/depression. Participants use Maya app 2 days/wk, 20 min/day. Assessments include questionnaires & optional MRI/EEG. Investigators think personalized program can be just as effective.
Who is the study for?
This trial is for young adults aged 18-25 with anxiety, depression, or bipolar disorder (currently in a depressive episode), who haven't started new psychotherapy or changed medication doses in the last 12 weeks. It's not for those with psychotic disorders, current manic episodes, or immediate suicide risk.
What is being tested?
The study compares two mobile apps delivering cognitive behavioral therapy: a standard version and a personalized one that introduces skills faster. Participants will use an app twice weekly for six weeks and undergo assessments including questionnaires and optional brain scans.
What are the potential side effects?
Since this trial involves non-invasive therapy through an app, there are no direct physical side effects like you'd expect from medication. However, discussing mental health can sometimes cause emotional discomfort.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline to end of active learning phase [week 4 for personalized intervention and week 6 for the general intervention]
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to end of active learning phase [week 4 for personalized intervention and week 6 for the general intervention]
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in anxiety symptoms from pre-intervention to post-intervention as measured by the HAM-A.
Change in anxiety symptoms from pre-intervention to post-intervention as measured by the anxiety subscale of the DASS.
Change in depressive symptoms from pre-intervention to post-intervention as measured by HAM-D.
+1 moreSecondary study objectives
Bipolar symptoms from pre-intervention to post-intervention as measured by ISS.
Change in Negative affect from pre-intervention to post-intervention as measured by PANAS
Change in anhedonia from pre-intervention to post-intervention as measured by TEPS.
+7 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: PersonalizedExperimental Treatment1 Intervention
Participants receive the personalized Maya app intervention for 6 weeks
Group II: General Non-PersonalizedActive Control1 Intervention
Participants receive the general MAYA app intervention for 6 weeks
Find a Location
Who is running the clinical trial?
Weill Medical College of Cornell UniversityLead Sponsor
1,077 Previous Clinical Trials
1,320,567 Total Patients Enrolled
4 Trials studying Bipolar Disorder
543 Patients Enrolled for Bipolar Disorder
Children's Health FundUNKNOWN
Jennifer Bress, Ph.D.Principal InvestigatorWeill Medical College of Cornell University
1 Previous Clinical Trials
60 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have been diagnosed with anxiety, depression, or bipolar disorder.My psychiatric medication dose hasn't changed in the last 3 months.I am between 18 and 25 years old.I have bipolar disorder and am currently stable or depressed.I have been diagnosed with anxiety, depression, or bipolar disorder.I started seeing a therapist for mental health within the last 3 months.I am currently undergoing cognitive behavior therapy.I have bipolar disorder and am currently in a depressive phase.
Research Study Groups:
This trial has the following groups:- Group 1: Personalized
- Group 2: General Non-Personalized
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger